SA Pharmaceutical Journal (SAPJ) official mouthpiece of the Pharmaceutical Society of South Africa (PSSA). SAPJ is aimed at the continuing professional development of the South African pharmacist as a clinical pharmaceutical care practitioner in a community or hospital pharmacy environment or in a regulatory position in the pharmaceutical industry. The journal provides specific clinical reviews on self-medication topics (symptomatic therapy), information on prescription medication (therapy in clinical context) and provides the pharmacists with essential information for referring customers for early medical attention should it be required. Pharmacovigilance – ensuring the safe and appropriate administration and use of medication and reporting of serious adverse events or other adverse drug reactions – is strongly advocated in SAPJ. The SAPJ further supports pharmacists to transform the pharmacy in an accessible, basic primary health care facility for preventing and treating PHC conditions through diagnosis, screening and treatment.

Novartis urges patients to play a role in safer medical treatment

NOVARTIS URGES PATIENTS TO PLAY A ROLE IN SAFER MEDICAL TREATMENT Marking World Patient Safety Day, Novartis calls on patients be proactive about communication and adverse event reporting Novartis South Africa has urged South Africans to become more involved in...

Award-winning DOC-U-MENTALLY film now available on DVD

AWARD-WINNING DOC-U-MENTALLY FILM NOW AVAILABLE ON DVD Doc-U-Mentally – an award-winning film about the extreme pressures junior doctors face in South Africa is now available on DVD for R200. The documentary that was produced and directed by Francois Wahl, follows the...

EthiQal 1st Birthday

A new take on medical professional indemnity (PI) protection for doctors is turning the traditional, controversial indemnity insurance model on its head.

HIV prevention possible for those at high risk: men who have sex with men and transgender people

Right to Care, with the support of the Global Fund to Fight AIDS, TB and Malaria is rolling out Pre-Exposure Prophylaxis (PrEP) at three sites in Gauteng and one in the Western Cape, targeting those at high risk for HIV exposure particularly men who have sex with men and transgender people.

Eye strain the new affliction of the digital generation

While digital device usage is soaring, global awareness of digital eye strain is low, according to a new international survey carried out by Novartis among 6,000 people.